Clinical Trials Logo

Carbon Monoxide Poisoning clinical trials

View clinical trials related to Carbon Monoxide Poisoning.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04118491 Withdrawn - Clinical trials for Carbon Monoxide Poisoning

Hyperbaric Oxygen for Carbon Monoxide Induced Chronic Encephalopathy

HACMICE
Start date: July 2020
Phase: N/A
Study type: Interventional

In some patients, a few days or weeks after recovery from carbon monoxide poisoning, new symptoms develop. These can affect mood, ability to think or remember clearly, and movements. Some people develop movement problems that are similar to Parkinson's disease. This damage to brain tissue is called "encephalopathy," and this study will look at the effect of pressurized oxygen therapy on long term, or chronic, encephalopathy.

NCT ID: NCT02931448 Withdrawn - Clinical trials for Carbon Monoxide Poisoning

Occult Carbon Monoxide Poisoning Detection by Pulsated Carboxymetry in an Emergency Department

MAS-CO
Start date: n/a
Phase:
Study type: Observational

In France, the carbon monoxide is one of the first causes of the accidental poisonings with approximately 8000 cases a year, among which 500 deaths. The severe forms are translated by neurological disorders even a coma or the death straight away. The more insidious forms with a little carboxyhémoglobine level give rise to frustrate clinical pictures, mimicking flu or intestinal syndromes. The syndrome post--intervallaire corresponds to the appearance of remote neuropsychiatric disorders of the poisoning. Its appearance and its gravity are not correlated in the gravity of the initial poisoning, however the precocity of the treatment tends to decrease its frequency. Carbon monoxide elimination is made under unchanged form in the expired air. In a spontaneous way, the half-life in ambient air is of the order of 4 hours. In ventilation in isobaric pure oxygen, the half-life is shortened at 80 minutes and in hyperbaric oxygen at 23 minutes. This imposes a fast diagnosis for two reasons: - For poisonings with low level, the more the investigators wait to measure the carboxyhémoglobine (HBCO), the more they risk not to detect it. - The oxygen therapy decreases the duration of the poisoning and thus the tissular suffering. Actually the risk is important to pass next to the diagnosis and to let leave a patient without adapted care and without technical intervention to eliminate the source of the poisoning. Presently, to make the diagnosis, the investigators possess the analysis of the blood HbCO by realization of gas of the venous blood, which are taken in emergencies, but very often a few hours after the end of the exposure at the source of poisoning, what is translated by a disappearance of the symptoms and an underestimate of the initial blood HbCO. Since 2005, MASIMO laboratory commercialize a pulse carboxymètre, the RAD 57, which allows to estimate the carboxyhémoglobinémie in a not invasive way. Lot of studies showed the interest of its use in the early screening of carbon monoxide poisonings, allowing a faster dosage of the blood HbCO, and thus an also faster adapted care.

NCT ID: NCT00280579 Withdrawn - Clinical trials for Carbon Monoxide Poisoning

Cyanide Poisoning in Fire Victims

Start date: January 2006
Phase: N/A
Study type: Observational

Aim: To determine the incidence of cyanide poisoning in fire victims. 20 consecutive patients will have the rest of their blood sample analyzed for cyanide.